食管鳞状细胞癌患者组织中RAB1A基因表达的相关研究及其临床意义

梁晓虎, 田海卫. 食管鳞状细胞癌患者组织中RAB1A基因表达的相关研究及其临床意义[J]. 中国中西医结合消化杂志, 2019, 27(8): 566-571. doi: 10.3969/j.issn.1671-038X.2019.08.02
引用本文: 梁晓虎, 田海卫. 食管鳞状细胞癌患者组织中RAB1A基因表达的相关研究及其临床意义[J]. 中国中西医结合消化杂志, 2019, 27(8): 566-571. doi: 10.3969/j.issn.1671-038X.2019.08.02
LIANG Xiao-hu, TIAN Hai-wei. The expression pattern and clinic value of RAB1A in esophageal squamous cell carcinoma[J]. Chin J Integr Tradit West Med Dig, 2019, 27(8): 566-571. doi: 10.3969/j.issn.1671-038X.2019.08.02
Citation: LIANG Xiao-hu, TIAN Hai-wei. The expression pattern and clinic value of RAB1A in esophageal squamous cell carcinoma[J]. Chin J Integr Tradit West Med Dig, 2019, 27(8): 566-571. doi: 10.3969/j.issn.1671-038X.2019.08.02

食管鳞状细胞癌患者组织中RAB1A基因表达的相关研究及其临床意义

详细信息
    作者简介:

    梁晓虎,男,本科,主治医师,研究方向:肿瘤

    通讯作者: 田海卫,E-mail:496854906@qq.com
  • 中图分类号: R735.1

The expression pattern and clinic value of RAB1A in esophageal squamous cell carcinoma

More Information
  • [目的]探讨RAB1A在食管鳞状细胞癌患者中的表达及其临床意义。[方法]采用实时荧光定量PCR检测课题组2013~2015年收集的126例确诊食管鳞状细胞癌患者的癌组织及对应癌旁正常组织中RAB1A的表达量,并根据其表达量高低分为高表达组和低表达组;分析RAB1A表达量与食管鳞状细胞癌患者临床特征、生存期之间的关系;通过过表达RAB1A的表达后检测其对食管鳞状细胞癌细胞系增殖、迁移和侵袭能力的影响。[结果]RAB1A在食管鳞状细胞癌组织中表达量高于对应癌旁正常组织(0.0113±0.0194 vs.0.0071±0.0098,P=0.0123);RAB1A高表达与食管鳞状细胞癌患者家族肿瘤史(P=0.002)、饮酒(P=0.005)、体质指数(P=0.001)、分期(P=0.024)、淋巴结转移(P<0.001)、远端转移(P<0.001)及分化程度(P<0.001)相关;RAB1A高表达与食管鳞状细胞癌患者生存期明显缩短(P<0.001)。RAB1A过表达后促进食管鳞状细胞癌细胞增殖(F=151.9,P<0.001)、transwell迁移(100.4±14.2 vs.51.2±10.6,P=0.009)、划痕实验迁移距离[(655.0±43.9)μm vs.(320.7±115.2) μm,P=0.0003]和transwell侵袭(79.2±13.4 vs.46.2±17.6,P=0.0014)。[结论]RAB1A在食管鳞状细胞癌中高表达,且高表达将缩短食管鳞状细胞癌患者生存期,过表达RAB1A能够促进食管鳞状细胞癌细胞增殖、迁移和侵袭能力。
  • 加载中
  • [1]

    Siegel R L, Miller K D, Jemal A.Cancer statistics, 2018[J].CA Cancer J Clin, 2018, 68 (1):7-30.

    [2]

    Allemani C, Matsuda T, Carlo V D, et al.Global surveillance of trends in cancer survival 2000-14 (CONCORD-3):analysis of individual records for37513025patients diagnosed with one of 18cancers from 322population-based registries in 71 countries[J].The Lancet, 2018, 391 (10125):1023-1075.

    [3]

    Nj K, Ab V, Ms C, et al.Global, regional, and national levels and causes of maternal mortality during 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet, 2014, 384 (9947):980-1004.

    [4]

    Zeng H, Zheng R, Zhang S, et al.Esophageal cancer statistics in China, 2011:Estimates based on 177cancer registries[J].Thorac Cancer, 2016, 7 (2):232-237.

    [5]

    杜灵彬, 魏文强.中国人群食管鳞癌生存分析研究新进展[J].实用肿瘤学杂志, 2018, 32 (4):344-348.

    [6]

    郑荣寿, 张思维, 吴良有, 等.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤, 2012, 21 (1):1-8.

    [7]

    Zheng R, Zeng H, Zhang S, et al.Estimates of cancer incidence and mortality in China, 2013[J].Chin J Cancer, 2017, 36 (1):66.

    [8]

    曾红梅, 郑荣寿, 张思维, 等.1989-2008年中国恶性肿瘤死亡趋势分析[J].中华肿瘤杂志, 2012, 34 (7):525-531.

    [9]

    Islami F, Chen W, Yu X Q, et al.Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013[J].Ann Oncol, 2017, 28 (10):2567-2574.

    [10]

    Nikoshkov A, Broliden K, Attarha S, et al.Expression pattern of the PRDX2, RAB1A, RAB1B, RAB5Aand RAB25genes in normal and cancer cervical tissues[J].Int J Oncol, 2015, 46 (1):107-112.

    [11]

    Tanaka M, Mun S, Harada A, et al.Hsc70contributes to cancer cell survival by preventing Rab1Adegradation under stress conditions[J].PLoS one, 2014, 9 (5):e96785.

    [12]

    Sanchez-gurmaches J, Guertin D A.mTORC1gRABs the Golgi[J].Cancer Cell, 2014, 26 (5):601-603.

    [13]

    Thomas J D, Zhang Y J, Wei Y H, et al.Rab1Ais an mTORC1activator and a colorectal oncogene[J].Cancer Cell, 2014, 26 (5):754-769.

    [14]

    Sun T, Wang X, He H H, et al.MiR-221promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A[J].Oncogene, 2014, 33 (21):2790-800.

    [15]

    Abd Elmageed Z Y, Yang Y, Thomas R, et al.Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes[J].Stem Cells, 2014, 32 (4):983-997.

    [16]

    Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185countries[J].CA Cancer J Clin, 2018, 68 (6):394-424.

    [17]

    Torre L A, Bray F, Siegel R L, et al.Global cancer statistics, 2012[J].CA Cancer J Clin, 2015, 65 (2):87-108.

    [18]

    Chen W, Zheng R, Baade P D, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2):115-132.

    [19]

    Chen W.Cancer statistics:updated cancer burden in China[J].Chin J Cancer Res, 2015, 27 (1):1.

    [20]

    Li W, Zheng J, Deng J, et al.Increased levels of the long intergenic non-protein coding RNA POU3F3promote DNA methylation in esophageal squamous cell carcinoma cells[J].Gastroenterology, 2014, 146 (7):1714-1726, e5.

    [21]

    Park J S, Heo J S, Chang H S, et al.Association analysis of member RAS oncogene family gene polymorphisms with aspirin intolerance in asthmatic patients[J].DNA Cell Biol, 2014, 33 (3):155-161.

    [22]

    Shimada K, Uzawa K, Kato M, et al.Aberrant expression of RAB1Ain human tongue cancer[J].Br J Cancer, 2005, 92 (10):1915-1921.

    [23]

    Ishida M, Ohbayashi N, Fukuda M.Rab1 Aregulates anterograde melanosome transport by recruiting kinesin-1to melanosomes through interaction with SKIP[J].Sci Rep, 2015, 5 (8):238.

    [24]

    Ruffell B, Chang-shtrachan D, Chan V, et al.RAB1A Promotes Oncogenesis in Colorectal Cancer via mTORC1Activation[J].Cancer Dis, 2014, 4 (12):1366.

  • 加载中
计量
  • 文章访问数:  381
  • PDF下载数:  236
  • 施引文献:  0
出版历程
收稿日期:  2019-04-24

目录